A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers

NCT06494345 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Asthma

Interventions

BIOLOGICAL: Genolair, solution for subcutaneous administration, 150 mg
BIOLOGICAL: Genolair, lyophilisate for the preparation of solution for subcutaneous administration
BIOLOGICAL: Xolair®, solution for subcutaneous administration, 150 mg

Sponsor

AO GENERIUM